NO20065233L - Polymorfe former av metyl (+)-(S)-alfa-(2-klorfenyl)-6,7-dihydrotieno[3,2-C]pyndin-5(4H)acetathydrobromid, klopidrogelhydrobromid - Google Patents

Polymorfe former av metyl (+)-(S)-alfa-(2-klorfenyl)-6,7-dihydrotieno[3,2-C]pyndin-5(4H)acetathydrobromid, klopidrogelhydrobromid

Info

Publication number
NO20065233L
NO20065233L NO20065233A NO20065233A NO20065233L NO 20065233 L NO20065233 L NO 20065233L NO 20065233 A NO20065233 A NO 20065233A NO 20065233 A NO20065233 A NO 20065233A NO 20065233 L NO20065233 L NO 20065233L
Authority
NO
Norway
Prior art keywords
hydrobromide
dihydrotieno
chlorophenyl
pyridine
methyl
Prior art date
Application number
NO20065233A
Other languages
English (en)
Norwegian (no)
Inventor
Keith Richard Lorimer
Alicia Tee Fuay Ng
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20065233L publication Critical patent/NO20065233L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO20065233A 2004-04-20 2006-11-14 Polymorfe former av metyl (+)-(S)-alfa-(2-klorfenyl)-6,7-dihydrotieno[3,2-C]pyndin-5(4H)acetathydrobromid, klopidrogelhydrobromid NO20065233L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56379604P 2004-04-20 2004-04-20
PCT/US2005/013146 WO2005103058A1 (fr) 2004-04-20 2005-04-18 Formes polymorphes d'hydrobromure d'acetate de methyl(+)-(s)-$g(a)-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h), hydrobromure de clopidrogel

Publications (1)

Publication Number Publication Date
NO20065233L true NO20065233L (no) 2006-11-14

Family

ID=34966201

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065233A NO20065233L (no) 2004-04-20 2006-11-14 Polymorfe former av metyl (+)-(S)-alfa-(2-klorfenyl)-6,7-dihydrotieno[3,2-C]pyndin-5(4H)acetathydrobromid, klopidrogelhydrobromid

Country Status (20)

Country Link
US (1) US20070088049A1 (fr)
EP (1) EP1756116A1 (fr)
JP (1) JP2007533744A (fr)
KR (1) KR20070012675A (fr)
CN (1) CN1997648A (fr)
AU (1) AU2005236034A1 (fr)
BR (1) BRPI0509997A (fr)
CA (1) CA2562507A1 (fr)
CR (1) CR8678A (fr)
EA (1) EA010831B1 (fr)
EC (1) ECSP066932A (fr)
IL (1) IL178680A0 (fr)
MA (1) MA28588B1 (fr)
MX (1) MXPA06012205A (fr)
NO (1) NO20065233L (fr)
NZ (1) NZ551371A (fr)
TN (1) TNSN06331A1 (fr)
UA (1) UA83919C2 (fr)
WO (1) WO2005103058A1 (fr)
ZA (1) ZA200608569B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
JP2007513889A (ja) * 2004-09-21 2007-05-31 テバ ファーマシューティカル インダストリーズ リミティド 結晶性クロピドグレル臭酸塩及びその調製方法
SI22492A (sl) * 2007-03-08 2008-10-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Polimorfne oblike klopidogrel hidrobromida
PE20091156A1 (es) * 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
ATE530172T1 (de) 2008-02-26 2011-11-15 Lesvi Laboratorios Sl Pharmazeutische formulierungen mit clopidogrel
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2779726B1 (fr) * 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
AU1816901A (en) * 1999-12-06 2001-06-12 Euro-Celtique S.A. Benzimidazole compounds having nociceptin receptor affinity
IL162461A0 (en) * 2001-12-18 2005-11-20 Teva Pharma Polymorphs of clopidogrel hydrogensulfate
US7074928B2 (en) * 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
HUP0200438A3 (en) * 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
CZ297472B6 (cs) * 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
GB0321256D0 (en) * 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
GB0325603D0 (en) * 2003-11-03 2003-12-10 Sandoz Ag Organic compounds
WO2005068471A1 (fr) * 2004-01-13 2005-07-28 Zentiva, A.S. Nouvelles formes cristallines d'hydrobromure de clopidogrel et leurs procedes de preparation
CN1922188A (zh) * 2004-02-24 2007-02-28 齐格弗里德通用国际股份公司 氯吡格雷之药学可接受的盐

Also Published As

Publication number Publication date
WO2005103058A1 (fr) 2005-11-03
CA2562507A1 (fr) 2005-11-03
JP2007533744A (ja) 2007-11-22
UA83919C2 (en) 2008-08-26
ZA200608569B (en) 2007-12-27
CN1997648A (zh) 2007-07-11
MA28588B1 (fr) 2007-05-02
KR20070012675A (ko) 2007-01-26
TNSN06331A1 (en) 2008-02-22
IL178680A0 (en) 2007-02-11
EP1756116A1 (fr) 2007-02-28
MXPA06012205A (es) 2007-01-31
EA010831B1 (ru) 2008-12-30
EA200601921A1 (ru) 2007-02-27
CR8678A (es) 2007-08-28
ECSP066932A (es) 2006-12-20
US20070088049A1 (en) 2007-04-19
BRPI0509997A (pt) 2007-10-16
NZ551371A (en) 2010-07-30
AU2005236034A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
EA200600064A1 (ru) Производные тиенопиридона как ингибиторы киназ
ZA200409862B (en) Benzofused heteroaryl derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
DE602004007239D1 (de) 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7 INHIBITOREN
WO2006107771A3 (fr) Pyrazolo[3,4-c]quinolines, pyrazolo[3,4-c]naphthyridines, analogues de ceux-ci, et procedes
WO2005009370A3 (fr) Composes de beta-carboline ainsi que leurs analogues et leur utilisation en tant qu'inhibiteurs de proteine kinase-2 activee par proteine kinase activee par des mitogenes
WO2005084296A3 (fr) Composes tricycliques fusionnes en tant qu'inhibiteurs de 17beta-hydroxysteroide deshydrogenase 3
CA2603830A1 (fr) Pyridine [2,3-b] pyrazinones
BG108868A (en) Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds
WO2007146124A3 (fr) Inhibiteurs de pde5 substitué
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
BR0313385A (pt) Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz
WO2005105753A3 (fr) Derives naphthalimides, procedes de fabrication et compositions pharmaceutiques les renfermant
NO20065233L (no) Polymorfe former av metyl (+)-(S)-alfa-(2-klorfenyl)-6,7-dihydrotieno[3,2-C]pyndin-5(4H)acetathydrobromid, klopidrogelhydrobromid
DE602004015096D1 (de) Neue polymorphe von olanzapin-hydrochlorid
NO20065322L (no) Clopidogrelsalt og polymere former derav
WO2006074919A3 (fr) Amides d'acide 3-amino-6-aryl-thieno[2,3-b]pyridine-2-carboxylique, preparations pharmaceutiques contenant ces composes et utilisation desdits composes comme inhibiteurs de la liberation de tnf$g(a)
ATE513834T1 (de) Verfahren zur herstellung von (s)-(+)- clopidogrelbase und deren salzen
SE0303451D0 (sv) New compounds
TW200603805A (en) CCR-1 antagonist compounds
WO2008108742A3 (fr) Formes polymorphes de bromhydrate de clopidogrel
HK1095828A (en) Thieno[3,2-b]pyridine-6-carbonitriles as protein kinase inhibitors
HK1076631A (zh) 噻嗯並[3，2-b]吡啶-6-腈及噻嗯並[2，3-b]吡啶-5-腈作為蛋白激酶抑制物
EP2079691B8 (fr) Derives d'indeno[1,2-b]indole substitues comme nouveaux inhibiteurs de la proteine kinase ck2 et leur utilisation comme agents antitumoraux, cytostatiques et diagnostiques
EA200801043A1 (ru) Способ получения оланзапина
UA92776C2 (en) Pyrrolo[3,2-c]pyridine-4-one 2-indolinone protein kinase inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application